Benzenemethanamine,N-2,3-butadien-1-yl-N-methyl-, hydrochloride (1:1)

Suppliers

Names

[ CAS No. ]:
16719-32-7

[ Name ]:
Benzenemethanamine,N-2,3-butadien-1-yl-N-methyl-, hydrochloride (1:1)

Chemical & Physical Properties

[ Boiling Point ]:
238.5ºC at 760mmHg

[ Molecular Formula ]:
C12H16ClN

[ Molecular Weight ]:
209.71500

[ Flash Point ]:
89.4ºC

[ Exact Mass ]:
209.09700

[ PSA ]:
3.24000

[ LogP ]:
3.26150

[ Vapour Pressure ]:
0.0423mmHg at 25°C

[ Index of Refraction ]:
1.522

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DP1925000
CHEMICAL NAME :
Benzylamine, N-2,3-butadienyl-N-methyl-, hydrochloride
CAS REGISTRY NUMBER :
16719-32-7
LAST UPDATED :
199012
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C12-H15-N.Cl-H
MOLECULAR WEIGHT :
209.74
WISWESSER LINE NOTATION :
1U1U2N1&1R &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
339 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
JPMSAE Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- Volume(issue)/page/year: 57,430,1968
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
156 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
JPMSAE Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- Volume(issue)/page/year: 57,430,1968
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
32 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
JPMSAE Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- Volume(issue)/page/year: 57,430,1968

Related Compounds

  • (3-Imidazolylpropyl)(1-methylpyrazolo[4,5-e]pyrimidin-4-yl)amine
  • N-[3-(1-cyclopropyl-1H-1,2,3,4-tetrazol-5-yl)phenyl]-2-phenylethene-1-sulfonamide
  • N-(3,4-dimethylphenyl)-2-{[2-(4-ethylphenyl)-5-phenyl-1H-imidazol-4-yl]sulfonyl}acetamide
  • N-(3,5-dimethoxyphenyl)-3,6-dimethyl[1,2]oxazolo[5,4-b]pyridine-4-carboxamide
  • 2-(4-oxo-3-(phenylsulfonyl)quinolin-1(4H)-yl)-N-phenylacetamide
  • 2-(3-((3,4-dimethylphenyl)sulfonyl)-4-oxoquinolin-1(4H)-yl)-N-phenylacetamide
  • 6-cyclopropyl-3-methyl-N-[4-(trifluoromethyl)phenyl][1,2]oxazolo[5,4-b]pyridine-4-carboxamide
  • 3,6-dimethyl-N-[4-(trifluoromethyl)phenyl][1,2]oxazolo[5,4-b]pyridine-4-carboxamide
  • 6-cyclopropyl-N-(2,5-dimethoxyphenyl)-3-methyl[1,2]oxazolo[5,4-b]pyridine-4-carboxamide
  • N-(2,5-dimethoxyphenyl)-3,6-dimethyl[1,2]oxazolo[5,4-b]pyridine-4-carboxamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.